COMBINATION COMPRISING RIBOCICLIB AND AMCENESTRANT Application WO-2022218956-A1 World Intellectual Property Organisation (WIPO) 20 Oct 2022
TREATMENT OF BREAST CANCER WITH AMCENESTRANT AND PALBOCICLIB Application WO-2022187392-A1 World Intellectual Property Organisation (WIPO) 09 Sep 2022
PANEL OF ER REGULATED GENES FOR USE IN MONITORING ENDOCRINE THERAPY IN BREAST CANCER Application WO-2022109395-A3 World Intellectual Property Organisation (WIPO) 04 Aug 2022